Losing weight during midlife can present unique challenges. Changes in hormone levels, body composition, and other factors can make weight management more difficult. At Alevizos Medical in Irvine, California, John G. Alevizos, DO, helps you navigate these changes through comprehensive family practice care.
Many people wonder whether they can use medications such as phentermine, Ozempic®, or Mounjaro® while receiving hormone replacement therapy. We offer customized weight loss programs tailored to your unique biology, along with hormone replacement therapy for women to help relieve menopausal symptoms.
When both treatments are appropriate, we consider how they may interact.
It is a common misconception that hormone replacement therapy (HRT) functions directly as a weight-loss treatment. Clinical evidence clarifies that hormone replacement therapy is not recommended as a primary treatment for obesity or weight loss. Instead, HRT is prescribed to treat symptoms associated with hormonal decline, such as hot flashes, night sweats, sleep disturbances, and mood shifts.
When medical weight loss and HRT are used concurrently, they are managed as two distinct, complementary tracks. HRT targets hormonal symptom relief, while weight-loss medications address metabolic regulation and appetite control.
For some women, relief from menopausal symptoms such as hot flashes and sleep disturbances may also make it easier to stay active and maintain healthy routines while managing their weight.
Hormonal shifts during menopause often bring significant changes in body composition, including increased abdominal fat and a shift in fat distribution. For individuals navigating obesity or overweight during midlife, prescription weight-loss medications may provide an effective intervention to support healthy weight management.
Semaglutide (Ozempic® or Wegovy®) and tirzepatide (Mounjaro® or Zepbound®) mimic the effects of gut hormones involved in appetite regulation and blood sugar control.
Ozempic and Mounjaro are approved for type 2 diabetes, while Wegovy and Zepbound are approved for weight management.
Phentermine works differently, acting as a short-term appetite suppressant.
These medications have different indications and considerations, including potential interactions with other treatments.
When combining weight-loss medications with HRT, the delivery route of your hormone therapy becomes an important medical consideration. Incretin-based injectable medications, including Ozempic® and Mounjaro®, work in part by delaying gastric emptying — the rate at which your stomach processes and empties food into the small intestine.
This delayed gastric emptying prolongs feelings of fullness, but the exact extent to which GLP-1 medications affect the absorption of oral hormone replacement therapy is not yet fully clear. While delayed digestion may potentially alter how some oral medications are absorbed, further research is ongoing to establish precise clinical impacts.
When evaluating hormone delivery routes alongside GLP-1 therapy, considerations differ depending on whether estrogen or progestogen is prescribed. Transdermal estrogen options — such as skin patches, gels, or sprays — are frequently preferred because they absorb directly through the skin into the bloodstream, bypassing the digestive system entirely and reducing cardiovascular and clot risks. Conversely, for women taking oral progestogens, maintaining adequate absorption is critical for endometrial protection; clinicians may monitor therapy closely or adjust dosing and delivery routes based on individual risk factors. Our medical team carefully evaluates each component of your treatment plan to ensure maximum safety and efficacy.
Achieving your health goals requires a personalized, medical approach. Whether you need hormone support, weight management, or general family practice care, we are here to guide you. To explore your options, schedule a virtual visit or contact our Irvine office today.
